Skip Ribbon Commands
Skip to main content
Biosafety hood lab work

 A Quality Associate in the Product Development Manufacturing Corps, works in a glove box in the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University's Foothills Campus.

Bacteriology

Non-mycobacterial bacteriology research in MIP is diverse and is directed towards drug resistant pathogens (e.g. Pseudomonas aeruginosa, Acinetobacter baumannii, and Burkholderia species) and emerging pathogens or bacteria of biodefense importance (e.g. Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis). Efforts include studying antibacterial resistance mechanisms, identification of novel drug targets, drug discovery and development, immunotherapy, bacterial physiology, mechanisms of pathogenesis, development of animal models for emerging infectious diseases and vaccine discovery. These studies are facilitated by state-of-the-art BSL2, BSL3 and ABSL3 laboratory facilities. Many of these are located in the Infectious Diseases Research Complex on CSU's Foothills Campus which includes the Rocky Mountain Regional Biocontainment Laboratory, one of only 13 such facilities nationwide.

John Belisle
M. tuberculosis, F. tularensis vaccine discovery and physiology
Ric Slayden
M. tuberculosis, B. pseudomallei, F. tularensis, and Y. pestis drug discovery and development
Herbert Schweizer
B. pseudomallei and P. aeruginosa antimicrobial resistance and drug discovery
Randy Basaraba
P. aeruginosa biofilms
Steve Dow
B. pseudomallei and F. tularensis immunotherapy, vaccines and animal models
Dean Crick
B. pseudomallei drug discovery and development
Richard Bowen
Animal models of infectious disease
Bradley Borlee
P. aeruginosa and B. pseudomallei biofilm development and pathogenesis